cisms. The pesticide industry now acknowledges that this issue is an important area for future research and evaluation. This position is very different from the pesticide industry's initial reactions to the report.
For the benefit of readers unfimiliar with this debate, we recapitulate the basic argument of the WRI report (2) . It The WRI report (2) also examined the limited amount of human evidence available. We drew attention to ongoing Canadian research into an Inuit population exposed through diet to organochlorine compounds, including pesticide residues. The pesticide industry scientists question the relevance of this research but base their criticism on the wrong study (5) . Following on that study, as the WRI report recounts, Eric Dewailly and his colleagues at the Laval University Hospital in Quebec initiated a prospective study of Inuit infants, examining chemical exposures, biomarkers of exposure, and clinical outcomes. Dewailly hypothesized that the high levels of organochlorines found in the typical Inuit diet were being passed in breast milk to infants, increasing their susceptibility to acute otitis media and other infectious diseases (6) . Their study found decreased T-helper/T-suppressor cell ratios and increased incidence of acute otitis media associated with increased duration of breast-feeding and organochlorine levels in milk (5) . It was also reported that exposed infants were hard to vaccinate because of insufficient antibody response to vaccines (8) .
The pesticide industry critique mischaracterizes this important research, which implicates organochlorines in immune disregulation and altered host resistance in a human population. Clearly, further research is warranted to sort out the role of pesticides from that of other organichlorines and to resolve other issues (9) .
The WRI report (2) Correspondence immunotoxic or health impacts. Nonetheless, they do show a pattern ofimmunotoxic effects consistent with the experimental evidence. The methodological weaknesses in these studies certainly do not exonerate pesticides as potential immunotoxicants. Rather, they emphasize the need for further properly designed epidemiological research, which is the conclusion the WRI report drew from them.
The WRI report (2) recommended that an expanded epidemiological research program be designed and organized, and we are happy that the pesticide industry has agreed to participate in an international expert meeting that will consider the serious issues involved in designing such research. We hope that this meeting will stimulate and enable a program of field research in exposed and vulnerable populations.
The WRI report (2) recommended that immunotoxicity testing of pesticides, as a condition of registration, be strengthened to reflect improved immunological methods, a need with which the pesticide industry concurred. We are happy that in the United States the EPA has announced increased testing requirements. However, these requirements will not be applied to pesticides already registered or reregistered. We hope that the pesticide industry will also voluntarily carry out this expanded battery of immunotoxicity tests on products already on the market.
It is evident that the conditions for safe use and disposal of pesticides are not now being met in much of the world. In view of the serious risks this poses to vulnerable populations, including the possibility of reduced resistance to widespread and often deadly communicable diseases, we hope that the pesticide industry will also cooperate actively in reducing unnecessary exposures. Robert 
